Your browser doesn't support javascript.
loading
Process evaluation of an academic-community-government partnership to reduce liver diseases attributable to hepatitis B virus.
Le, Daisy; Jeon, Min Jeong; Ciceron, Annie Coriolan; Yang, Y Tony; Pan, Jane; Juon, Hee-Soon; Wallington, Sherrie F.
Afiliação
  • Le D; The George Washington University, School of Nursing, 1919 Pennsylvania Ave NW, Suite 500, Washington, DC, 20006, USA. daisyle@gwu.edu.
  • Jeon MJ; The George Washington University, Milken Institute School of Public Health, 950 New Hampshire Ave NW #2, Washington, DC, 20052, USA. daisyle@gwu.edu.
  • Ciceron AC; The George Washington University, School of Nursing, 1919 Pennsylvania Ave NW, Suite 500, Washington, DC, 20006, USA.
  • Yang YT; The George Washington University, School of Nursing, 1919 Pennsylvania Ave NW, Suite 500, Washington, DC, 20006, USA.
  • Pan J; The George Washington University, School of Nursing, 1919 Pennsylvania Ave NW, Suite 500, Washington, DC, 20006, USA.
  • Juon HS; The George Washington University, Milken Institute School of Public Health, 950 New Hampshire Ave NW #2, Washington, DC, 20052, USA.
  • Wallington SF; Hepatitis B Initiative of Washington DC (HBI-DC), 1725 I St NW #300, Washington, DC, 20006, USA.
BMC Health Serv Res ; 22(1): 707, 2022 May 26.
Article em En | MEDLINE | ID: mdl-35619128
ABSTRACT

BACKGROUND:

Racial/ethnic minorities have higher incidence and mortality rates of liver cancer, or hepatocellular carcinoma, than non-Hispanic Whites. As such, the Washington-Baltimore Metropolitan Area Hepatitis B Virus (WB-HBV) Demonstration Project, a community-based participatory research (CBPR)-driven academic-community-government (ACG) partnership, was established in 2019 to address disparities and implement strategies to improve the HBV screening and vaccination infrastructure for at-risk communities. CBPR is a partnership of community members, organizational leaders, and academic researchers with a common aim to collectively share and contribute their input at every phase of the project. Herein, we describe the process evaluation of the WB-HBV Project and extract themes and insights to benefit future ACG partnerships and community-engaged research. The process evaluation has been conducted to determine whether CBPR-driven partnership and programmatic activities have been implemented as intended and have resulted in building expanded research capacity for future ACG partnership HBV community-level initiatives.

METHODS:

A WB-HBV Project Task Force was convened and comprised of eight organizations four community organizations, three government organizations, and one academic institution. Through a mixed-methods process evaluation, an online survey and key informant interviews were conducted to provide context for program implementation barriers and facilitators. Descriptive statistics were conducted, and interviews were recorded, transcribed, and thematically coded.

RESULTS:

The survey was completed by 14 of 20 partnership members (70.0%) two academic, eight community, and four government members. Partnership members showed general agreement across 14 domains organization and structure of meetings; trust; decisions; impact; general satisfaction; strategic planning; ACG policy impact; community-based participatory research and government; participation in meetings; assessment of participation; partnership operations and capacity; communication; challenges/limitations associated with ACG involvement; and benefits compared to challenges associated with ACG involvement. Qualitative interviews were conducted with 15 of the 20 members (75.0%) two academic, nine community, and four government members. Four themes emerged partnership involvement, project goals and accomplishments, project challenges and barriers, and partnership involvement in government or policy.

CONCLUSIONS:

The process evaluation presents insights into developing strategies to enhance partnership functioning and increase the ability of present and future ACG partnerships to improve community health outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Hepatopatias Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Hepatopatias Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article